Trulieve Cannabis Corp.
TRUL
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.19B | 1.19B | 1.19B | 1.17B | 1.16B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.19B | 1.19B | 1.19B | 1.17B | 1.16B |
| Cost of Revenue | 458.84M | 461.47M | 470.75M | 489.74M | 511.00M |
| Gross Profit | 726.44M | 725.16M | 715.75M | 682.58M | 652.25M |
| SG&A Expenses | 526.45M | 527.92M | 510.45M | 448.80M | 394.03M |
| Depreciation & Amortization | 115.73M | 114.38M | 112.81M | 111.36M | 109.99M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.10B | 1.10B | 1.09B | 1.05B | 1.02B |
| Operating Income | 84.26M | 82.87M | 92.49M | 122.41M | 148.23M |
| Income Before Tax | 33.49M | 31.10M | 42.71M | 64.44M | 91.00M |
| Income Tax Expenses | 202.14M | 194.62M | 197.59M | 195.44M | 184.70M |
| Earnings from Continuing Operations | -168.65 | -163.52 | -154.88 | -131.01 | -93.70 |
| Earnings from Discontinued Operations | -4.64M | -5.97M | -5.70M | -2.80M | -4.09M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.64M | 4.59M | 5.47M | 5.05M | 3.86M |
| Net Income | -166.65M | -164.90M | -155.11M | -128.75M | -93.93M |
| EBIT | 84.26M | 82.87M | 92.49M | 122.41M | 148.23M |
| EBITDA | 254.34M | 251.19M | 258.86M | 288.32M | 313.95M |
| EPS Basic | -0.88 | -0.87 | -0.82 | -0.68 | -0.50 |
| Normalized Basic EPS | 0.13 | 0.12 | 0.15 | 0.24 | 0.30 |
| EPS Diluted | -0.88 | -0.87 | -0.82 | -0.68 | -0.50 |
| Normalized Diluted EPS | 0.13 | 0.12 | 0.15 | 0.24 | 0.30 |
| Average Basic Shares Outstanding | 762.52M | 761.65M | 760.01M | 759.01M | 757.74M |
| Average Diluted Shares Outstanding | 762.52M | 761.65M | 760.01M | 759.01M | 757.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |